Jane Koh
- Hepatology top 1%
- Epidemiology top 5%
- Oncology top 5%
- Molecular Biology
- Cancer Research top 10%
- Co-authors
- Winnie YeoFrankie MoTony MokStephen L. ChanAnthony T.�C. ChanPaul B.S. LaiPhilip J. JohnsonSimon C.H. Yu
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (16 papers)Liver Disease Diagnosis and Treatment (10 papers)Hepatitis B Virus Studies (6 papers)
- Cited by
- HepatologyOncologyEpidemiology
- Partner nations
- Hong KongChinaUnited Kingdom
In The Last Decade
Jane Koh
31 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 94
- Hepatology 849
- Epidemiology 568
- Oncology 493
- Molecular Biology 421
- Cancer Research 246
Countries citing papers authored by Jane Koh
This map shows the geographic impact of Jane Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Koh more than expected).
Fields of papers citing papers by Jane Koh
This network shows the impact of papers produced by Jane Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Koh. The network helps show where Jane Koh may publish in the future.
Co-authorship network of co-authors of Jane Koh
This figure shows the co-authorship network connecting the top 25 collaborators of Jane Koh. A scholar is included among the top collaborators of Jane Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Koh. Jane Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 32 | |
| 3 | 6 | |
| 4 | 8 | |
| 5 | 13 | |
| 6 | 24 | |
| 7 | 24 | |
| 8 | 38 | |
| 9 | 11 | |
| 10 | 26 | |
| 11 | 104 | |
| 12 | 2 | |
| 13 | 172 | |
| 14 | 159 | |
| 15 | 72 | |
| 16 | 2 | |
| 17 | 51 | |
| 18 | 95 | |
| 19 | 467 | |
| 20 | 42 |
About Jane Koh
Jane Koh is a scholar working on Hepatology, Cancer Research and Oncology, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Hepatology (849 citations), Oncology (493 citations) and Epidemiology (568 citations). Jane Koh has collaborated with scholars based in Hong Kong, China and United Kingdom. Frequent co-authors include Winnie Yeo, Frankie Mo, Tony Mok, Stephen L. Chan, Anthony T.�C. Chan, Paul B.S. Lai, Philip J. Johnson, Simon C.H. Yu, Benny Zee and Brigette Ma. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.